FDA's cosmetics oversight presence was less pronounced in 2017 compared with the prior year, and the agency could fade further into the background over the next couple of years as it focuses its limited resources on higher priority areas.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?